Internal Medicine, Rheumatology · Gainesville, GA
NPI
1336102425
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
700 S Enota Dr NE
Gainesville, GA, 30501
Phone (770) 531-3711
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
168,100 services
Medicare patients, 2024
653
Average age 74
Drug cost, 2024
$8.0M
8,176 prescriptions
Company payments, 2025
$3,777
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marta T Bognar was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 48,860 times for 31 patients. In total Marta T Bognar billed 168,100 services in 80 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 48,860 | 31 | $3.52 | $172K |
| J3262 Injection, tocilizumab, 1 mg | Office | 35,420 | 21 | $4.70 | $167K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 28,470 | 61 | $9.05 | $258K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 18,525 | 59 | $33.78 | $626K |
| J9312 Injection, rituximab, 10 mg | Office | 6,991 | 48 | $61.30 | $429K |
| J0897 Injection, denosumab, 1 mg | Office | 3,240 | 40 | $20.48 | $66K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,736 | 17 | $24.37 | $67K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,500 | 18 | $0.10 | $155 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,436 | 43 | $0.22 | $321 |
| 99214 Office E&M - Established | Office | 738 | 374 | $89.41 | $66K |
| 36415 Venipuncture Blood Collection | Office | 707 | 360 | $8.60 | $6,082 |
| 96413 Chemotherapy Administration | Office | 590 | 214 | $94.15 | $56K |
| 86140 Clinical Chemistry | Office | 361 | 261 | $5.02 | $1,813 |
| 85652 Clinical Chemistry | Office | 355 | 256 | $2.62 | $930 |
| 80053 Clinical Chemistry | Office | 315 | 228 | $10.22 | $3,219 |
By year: 2022 $2.7M for 222,830 services; 2023 $2.4M for 201,385 services; 2024 $2.2M for 168,100 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 707 | 360 | $8.60 | $6,082 |
| 86140 Clinical Chemistry | 361 | 261 | $5.02 | $1,813 |
| 85652 Clinical Chemistry | 355 | 256 | $2.62 | $930 |
| 80053 Clinical Chemistry | 315 | 228 | $10.22 | $3,219 |
| 85025 Blood Count | 305 | 221 | $7.51 | $2,290 |
| 83516 Immunoassay | 28 | 14 | $11.30 | $316 |
| 82306 Clinical Chemistry | 26 | 26 | $28.12 | $731 |
| 84550 Clinical Chemistry | 18 | 17 | $4.43 | $79.74 |
| 86200 Immunoassay | 17 | 17 | $12.15 | $207 |
| 82550 Clinical Chemistry | 16 | 11 | $6.38 | $102 |
Medicare prescription drug claims, 2024
In 2024, the drug Marta T Bognar prescribed most often to Medicare patients was Prednisone, with 1,817 prescriptions and refills. In total Marta T Bognar wrote 8,176 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,817 | 2,843 | 455 | $11K |
| Methotrexate Methotrexate Sodium | 1,277 | 1,985 | 235 | $22K |
| Hydroxychloroquine Sulfate Generic | 1,030 | 1,850 | 235 | $38K |
| Leflunomide Generic | 328 | 593 | 69 | $13K |
| Sulfasalazine Generic | 315 | 531 | 74 | $6,951 |
| Allopurinol Generic | 294 | 557 | 64 | $2,391 |
| Gabapentin Generic | 206 | 356 | 53 | $3,332 |
| Tramadol Hcl Generic | 203 | 208 | 35 | $994 |
| Enbrel Sureclick Etanercept | 156 | 178 | 20 | $1.3M |
| Humira(Cf) Pen Adalimumab | 143 | 177 | 26 | $1.3M |
| Colchicine Generic | 139 | 212 | 35 | $12K |
| Rinvoq Upadacitinib | 110 | 132 | 16 | $840K |
| Pregabalin Generic | 108 | 131 | 22 | $2,143 |
| Cyclobenzaprine Hcl Generic | 104 | 134 | 21 | $799 |
| Febuxostat Generic | 100 | 177 | 20 | $8,674 |
Brand drugs: - claims; generic drugs: 6,708 claims; opioid claims: 222.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marta T Bognar $3,777 ($3,402 in general payments such as food, travel and fees and $375 for research) from 21 companies. The largest payer was Abbvie Inc. with $704.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 39 | $704 |
| Novartis Pharmaceuticals Corporation NVS | 29 | $645 |
| Amgen Inc. AMGN | 27 | $513 |
| Eli Lilly and Company LLY | 1 | $375 |
| Janssen Biotech, Inc. JNJ | 14 | $356 |
| UCB, Inc. UCB.BR | 14 | $274 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $160 |
| Pfizer Inc. PFE | 7 | $148 |
| Radius Health, Inc. | 4 | $108 |
| Genzyme Corporation SNY | 3 | $76.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.